Dyspareunia
QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena(TM) (Ospemifene Tablets) in Treatment of Postmenopausal Vaginal Atrophy
Published in Law and Health Weekly, September 26th, 2009
QuatRx Pharmaceuticals Company, a privately-held biopharmaceutical company, announced positive efficacy results from the second of two patient cohorts in the second pivotal Phase 3 study for Ophena™ (ospemifene tablets), the company's investigational compound in development for the treatment of postmenopausal vulvovaginal atrophy (VVA). This study, together with the recent completion of a long-term safety study for Ophena™, marks the end of the company's comprehensive Phase 3 efficacy and safety program for Ophena™ and positions QuatRx to file a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) in early 2010.
This second phase...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- AARP Illinois
AARP Delivers Health Care Reform 'Message in a Bottle' in Chicago - AARP Illinois
AARP Delivers Health Care Reform 'Message in a Bottle' to Cong. Hare - Advanced Micro-Fabrication Equipment Inc.
Advanced Micro-Fabrication Equipment, Inc Prevails in Patent Infringement Suit Filed Against the Company by Lam Research in Taiwan - Aetna
Aetna and the Aetna Foundation Sponsor Health Affairs Issue Offering Solutions to Address Rising Health Care Costs - Aging
Research on aging published by L.H. Plawecki et al - American Medical Association
AMA Reaction to President Obama's Address on Health-System Reform - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
